Terns Pharmaceuticals Inc (NASDAQ: TERN) kicked off on Friday, down -6.06% from the previous trading day, before settling in for the closing price of $37.77. Over the past 52 weeks, TERN has traded in a range of $1.87-$48.26.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 16.38%. While this was happening, its average annual earnings per share was recorded 3.15%. With a float of $89.96 million, this company’s outstanding shares have now reached $106.33 million.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 15.40%, while institutional ownership is 69.24%. The most recent insider transaction that took place on Jan 05 ’26, was worth 2,718,230. In this transaction Chief Executive Officer of this company sold 71,339 shares at a rate of $38.10, taking the stock ownership to the 138,976 shares. Before that another transaction happened on Jan 02 ’26, when Company’s Chief Medical Officer sold 1,155 for $38.57, making the entire transaction worth $44,552. This insider now owns 50,365 shares in total.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.24 earnings per share (EPS), higher than consensus estimate (set at -0.3) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.53% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Take a look at Terns Pharmaceuticals Inc’s (TERN) current performance indicators. Last quarter, stock had a quick ratio of 19.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.18 in one year’s time.
